Middle East and Africa Liposome Drug Delivery Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, DepoFoam Liposome Technology, and Lysolipid Thermally Sensitive Liposome (LTSL) Technology); Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, and Photodynamic Therapy), and Country

No. of Pages: 125
Report Code: TIPRE00016252
Category: Life Sciences
Middle East and Africa Liposome Drug Delivery Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East and Africa Liposome Drug Delivery Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East and Africa Liposome Drug Delivery Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East and Africa Liposome Drug Delivery Market Regional Analysis

6.2 Middle East and Africa Liposome Drug Delivery Market Revenue 2017-2027 (US$ Million)
6.3 Middle East and Africa Liposome Drug Delivery Market Forecast Analysis

7. Middle East and Africa Liposome Drug Delivery Market Analysis – by Product

7.1 Liposomal Doxorubicin
  • 7.1.1 Overview
  • 7.1.2 Liposomal Doxorubicin: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Liposomal Paclitaxel
  • 7.2.1 Overview
  • 7.2.2 Liposomal Paclitaxel: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Liposomal Amphotericin B
  • 7.3.1 Overview
  • 7.3.2 Liposomal Amphotericin B: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Middle East and Africa Liposome Drug Delivery Market Analysis – by Technology

8.1 Stealth Liposome Technology
  • 8.1.1 Overview
  • 8.1.2 Stealth Liposome Technology: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Non-PEGylated Liposome Technology
  • 8.2.1 Overview
  • 8.2.2 Non-PEGylated Liposome Technology: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 DepoFoam Liposome Technology
  • 8.3.1 Overview
  • 8.3.2 DepoFoam Liposome Technology: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Lysolipid Thermally Sensitive Liposome Technology
  • 8.4.1 Overview
  • 8.4.2 Lysolipid Thermally Sensitive Liposome Technology: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Middle East and Africa Liposome Drug Delivery Market Analysis – by Application

9.1 Fungal Diseases
  • 9.1.1 Overview
  • 9.1.2 Fungal Diseases: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Cancer Therapy
  • 9.2.1 Overview
  • 9.2.2 Cancer Therapy: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Pain Management
  • 9.3.1 Overview
  • 9.3.2 Pain Management: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.4 Viral Vaccines
  • 9.4.1 Overview
  • 9.4.2 Viral Vaccines: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.5 Photodynamic Therapy
  • 9.5.1 Overview
  • 9.5.2 Photodynamic Therapy: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Middle East and Africa Liposome Drug Delivery Market – Middle East and Africa Analysis

10.1 Overview

10.2 Middle East and Africa
  • 10.2.1 Middle East and Africa Liposome Drug Delivery Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.2.1.1 Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 South Africa: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.1.1 South Africa: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Product
    • 10.2.1.1.2 South Africa: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Technology
    • 10.2.1.1.3 South Africa: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Application
  • 10.2.1.2 Saudi Arabia: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.2.1 Saudi Arabia: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Product
    • 10.2.1.2.2 Saudi Arabia: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Technology
    • 10.2.1.2.3 Saudi Arabia: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Application
  • 10.2.1.3 UAE: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.3.1 UAE: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Product
    • 10.2.1.3.2 UAE: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Technology
    • 10.2.1.3.3 UAE: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Application
  • 10.2.1.4 Rest of Middle East and Africa: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Product
    • 10.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Technology
    • 10.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Liposome Drug Delivery Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 ASTELLAS PHARMA INC.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 JOHNSON AND JOHNSON SERVICES, INC.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 LUYE PHARMA GROUP
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 NOVARTIS AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Middle East and Africa Liposome Drug Delivery Market

  • ASTELLAS PHARMA INC.
  • JOHNSON AND JOHNSON SERVICES, INC.
  • LUYE PHARMA GROUP
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • NOVARTIS AG

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)